SciELO - Scientific Electronic Library Online

 
vol.30 número4Modulación de tono autonómico y trabajo en turno de noche: un estudio prospectivo en residentes médicos en Medellín, ColombiaRCP sólo con las manos y DEA de acceso público, la necesidad de implementar áreas cardio-protegidas en México índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Cardiovascular and metabolic science

versión On-line ISSN 2954-3835versión impresa ISSN 2683-2828

Cardiovasc. metab. sci vol.30 no.4 Ciudad de México oct./dic. 2019  Epub 12-Ago-2024

 

Review

Electrocardiographic abnormalities in subarachnoid hemorrhage

Anomalías electrocardiográficas en hemorragia subaracnoidea

José Miguel Gloria Escobar1  * 

Juan Pablo Zuluaga García1 

Laura Duque González2 

Carlos Aníbal Restrepo Bravo3 

1 Medical student, School of Medicine. CES University. Antioquia, Colombia.

2 Cardiology Fellow. CES University. Antioquia, Colombia.

3 Associate Professor, Medical Sciences, School of Medicine. CES University. Antioquia, Colombia.


Abstract:

Electrocardiogram abnormalities are particularly common among patients with subarachnoid hemorrhage (SAH). Phenomena such as ventricular tachycardia and fibrillation, torsade de pointes (mainly when a QTc is prolonged), sinus bradycardia, sinus tachycardia, atrial fibrillation, wandering atrial pacemaker, premature atrial, junctional, and ventricular complexes, atrioventricular block, neurogenic T waves, peaked P waves, shortened PR interval, inverted U waves and ST segment deviations have been described. Not only can these abnormalities mimic myocardial infarction or myocardial ischemia, but they also share an important prevalence with wall motion abnormalities like the Takotsubo cardiomyopathy. There have been few studies involving Holter monitoring in these patients, which constitutes an investigation subject with aims to standardize these complications in order to avoid adversely affecting discharge disposition and prolong in-hospital staying.

Keywords: Electrocardiogram; subarachnoid hemorrhage; giant T wave; arrythmias; ventricular fibrillation; ventricular tachycardia

Resumen:

Las anormalidades en el electrocardiograma son particularmente comunes en los pacientes con hemorragia subaracnoidea. Se han descrito fenómenos como la taquicardia y fibrilación ventriculares, taquicardia de puntas torcidas (principalmente cuando el intervalo QTc se encuentra prolongado), marcapaso atrial migratorio, complejos atriales, de la unión y ventriculares prematuros, bloqueo auriculoventricular, ondas T neurogénicas, ondas P picudas, acortamiento del intervalo PR, ondas U invertidas y desviaciones del segmento ST. Estas anormalidades no sólo pueden simular isquemia o infarto del miocardio, sino que también comparten una importante prevalencia con otras de la motilidad de la pared miocárdica, como la cardiomiopatía de Takotsubo. Pocos estudios han utilizado el monitoreo Holter en estos pacientes, lo que constituye un tema de investigación con miras a estandarizar este tipo de complicaciones para evitar afectar de forma adversa el alta de estos pacientes o prolongar su estancia hospitalaria.

Palabras clave: Electrocardiograma; hemorragia subaracnoidea; onda T gigante; arritmias; fibrilación ventricular; taquicardia ventricular

Introduction

Subarachnoid hemorrhage (SAH) affects 30,000 people between the mid and late adulthood in the United States annually. It has a mortality rate of 30 to 45% and is more likely due to a congenital cranial base aneurysm rupture, followed by an aneurysm rupture of infectious or traumatic etiology and an arteriovenous malformation rupture.1 Approximately 15-20% of patients with SAH do not have a vascular lesion on initial four-vessel cerebral angiography, and the causes of this phenomenon are diverse and often not identified.2 Although SAH has a high mortality rate, it has been declining over time in western population; probably due to improvements in rate of smoking, hypertension, its clinical management, diagnostic accuracy and therapeutic measures.3

Apart from a clinical suspicion of a SAH based on a wide variety of signs including severe headache of abrupt onset, nausea, vomiting, nuchal rigidity and consciousness alteration, the electrocardiogram (ECG) can portray specific waveform morphology and rhythm alterations.1 It has been evidenced in previous studies that SAH is associated with a variety of cardiac alterations, which include ventricular tachycardia and fibrillation (mainly when a QTc is prolonged), torsade de pointes, sinus bradycardia, sinus tachycardia or atrial fibrillation, among others.1

Prevalence of ECG abnormalities in SAH patients

The prevalence of ECG abnormalities in SAH patients has been previously reported to range between 27 and 100%. This wide range of prevalence may be due to errors in study methods, number of patients or ECG readings. Because neurological patients do not routinely have ECG, underregistration is a common problem.1 Another observation is that even though some might consider ECG recordings prior to the SAH not important, these should also be included to have an objective comparison in order to better risk-stratify patients, especially in the first hours following the hemorrhage. Brouwers et al found that the most pronounced ECG changes occurred during the first 72 hours after SAH,4 while Di Pasquale et al found that 90% of patients had ECG abnormalities in the first 48 hours.5 These results outline the importance of starting early ECG monitoring in these patients.

Pathophysiology

Crompton and Smith, suggested that the hemorrhage causes localized arteriolar vasospasm resulting in ischemic damage to the hypothalamus and its periphery.6,7 This type of damage induces catecholamine release directly via the upper cervical sympathetic chain and indirectly via the pituitary-adrenal axis. Greenhoot et al, and Melville et al, demonstrated that direct electrical stimulation of the hypothalamus results in ECG abnormalities resembling those seen in SAH patients.8,9 Rogers et al, reproduced constant changes in T waves by stimulating the right and left side of the hypothalamus and stellate ganglia respectively, which suggest a neurogenic response that ultimately is responsible for any particular changes in rhythm and myocardial wall.10 Cruickshank et al, conducted a trial with 46 patients diagnosed with SAH by lumbar puncture recording a total of 197 ECGs and measured mean urinary catecholamines, mean urinary normetanephrine, mean urinary metanephrine and mean plasma cortisol. This trial demonstrated a statically significant correlation with high levels of plasma cortisol (100 μg/mL) with peaked P-waves (n = 40, plasma cortisol [PC] = 27 ± 10.8, p < 0.01), peaked T-waves (n = 21, PC = 27.3 ± 7.8, p < 0.05) and a PR interval lasting shorter than 0.13 msec (n = 11, PC = 27.5 ± 10, p < 0.01), as well as high mean urinary catecholamine values in the abnormal ECG group in a period of 2 weeks.11 Parekh et al found that patients with elevations in cardiac troponin I were more likely to have ECG abnormalities than patients without elevations in the biomarker.12

In general, factors that influence the development of ECG and ventricular function abnormalities include cerebral vasospasm (discussed above), hypoxia, electrolyte imbalance, and sudden increase in intracranial pressure triggering a sympathetic or vagal discharge due to compression or direct ischemic damage of brain structures,1 particularly, the hypothalamus.

Morphological wave changes

These are primarily alterations in repolarization encompassing the T wave, U wave, ST segment and QTc interval. ST-segment elevation or depression and T wave inversion are frequently confused with myocardial infarction (Figures 1 and 2).1,13 In the most extensive study ever done on the matter, Rudehill et al14 recruited 406 patients who were submitted to SAH preoperative ECG monitoring, and findings included high-amplitude R waves in 19% of subjects, ST depression in 15%, T-wave abnormalities in 32%, U waves greater than 1 mm in amplitude in 47%, and prolonged QTc interval (> 440 msec) in 23% of the patients. In a different study, Q wave alterations were found in 4 SAH patients after surgery and T wave alterations in 15 of them.15 A prolonged QTc interval and abnormally large T waves were also noted. These «cerebral» or «neurogenic» T waves are characterized by slurring, and having a broad base; although they can be notched or even flat.1

Figure 1: Schematic representation of the most common ECG findings on precordial leads (V3-V5): a. Short PR interval, b. ST segment depression, c. inverted and broad-based T wave. 

Figure 2: 24-hour Holter monitoring on a 64-year-old female with SAH. Recordings reveal characteristic inverted broad T waves and ST-segment depression. Taken with permission from CES Cardiology electrocardiographic database. Medellín, Colombia. 

In a relatively large study, a total of 61 patients for 12 days or until surgery occurred with a 12-lead ECG and cardiac monitoring for arrhythmias; of these patients, 26 had daily 12-lead ECG readings, and 43 of them had readings three times per week. The most common findings were prominent U waves, ischemic T waves, ST-segment elevation or depression, indicators of left ventricular hypertrophy, flat T waves and short PR interval.4 Melin and Fogelholm found ECG changes in 86% of 14 subjects who died within seven days of SAH and in 73% of 62 subjects who survived more than 7 days.16 A total of 26 patients died within the first 6 hours of SAH instauration (even before an ECG could be obtained). Common findings among the obtained ECGs were abnormal Q waves, ST-segment deviation, neurogenic T waves and QTc longer than 430 msec. In the one study that included Holter monitoring, a 12-lead ECG and cardiac monitoring from 120 patients with SAH, were obtained on the day of admission. Changes included ST-segment deviations in 37% of patients, prominent U waves in 16%, and T-wave abnormalities in 12%. Also, 42% of patients had a prolonged QTc interval. Transitory ST-segment depression greater than 1.5 mm lasting 10 to 30 minutes was detected in 7 patients. ST-segment elevation lasting 20 minutes occurred in 1 patient during cerebral angiography along with bigeminal premature ventricular complexes. Abnormalities involving atrial depolarization including notably peaked P waves (> 2.5 mm in amplitude) and short PR intervals (< 100 msec), were also observed.5

Arrhythmias

Despite flaws in accurately monitoring for arrhythmias in previous studies, several alterations have been reported, such as sinus bradycardia, sinus tachycardia, wandering atrial pacemaker, atrial fibrillation, premature atrial, junctional, and ventricular complexes (Figure 3); atrioventricular block, torsade de pointes and ventricular tachycardia.1

Figure 3: Twelve lead ECG in a 53-year-old man admitted to the intensive care unit due to SAH, exposing complete AV block with escape junctional rhythm, T wave inversion in precordial leads and 2 ventricular premature complexes. Taken with permission from CES Cardiology electrocardiographic database. Medellín, Colombia. 

In his study, Di Pasquale et al, obtained a total of 107 correct Holter readings, and cardiac arrhythmias were detected in 96 (90%) of the 107 patients, premature ventricular complexes, including multiform premature ventricular complexes, couplets or triplets, and the R-on-T phenomenon, were detected in 49 patients (46%) and five of the patients with frequent premature ventricular complexes also had non-sustained ventricular tachycardia (defined as 3 or more consecutive premature ventricular complexes, torsade de pointes occurred in 4 patients and progressed to ventricular fibrillation and asystole in 1 of the 4.5

Holter monitoring was repeated 48 hours later in all patients who had malignant alterations, but no further arrhythmias occurred. Of the 107 patients, 39 (36%) had supraventricular arrhythmias, including premature supraventricular complexes, non-sustained supraventricular tachycardia, and atrial fibrillation.1 Thirty-two patients (30%) had sinus tachycardia (heart rate > 120/min), 32 (30%) sinus arrhythmia, 42 (39%) sinus bradycardia (heart rate < 50/min), and 23 (21%) sinoatrial blocks. Other rhythm disturbances, such as wandering pacemaker, sinus arrest greater than 3 seconds, 2:1 atrioventricular block, atrioventricular dissociation, and idioventricular rhythm were also found.1 Di Pasquale et al, found that both severity and frequency of arrhythmias were more significant in the 62 patients studied within 48 hours of SAH onset and that patients with malignant ventricular arrhythmias had a much more prolonged QTc interval (590 ± 52 msec) and serum levels of potassium less than 3.5 mmol/L.5

Wall motion abnormalities

Abnormalities in the myocardial wall movement can certainly confuse the attending physician when it comes to reading an ECG; especially given the fact that they can sometimes suggest other pathological entities such as myocardial ischemia or acute myocardial infarction.17 Although these changes have been reported to be benign in most cases, there is a significant prevalence of other very similar pathologies associated with SAH that can threaten the patient´s life and most always be taken in consideration and differentiated.18-20 For instance, the type of resemblance that these abnormalities have with myocardial infraction in ECG recordings can not only generate delay and confusion at the time of diagnosis, but also create possible incorrect therapeutic actions that can aggravate the patient’s condition such as antiplatelet, anticoagulant and fibrinolytic therapy.21

Taking into account that the alterations found in the ECG are not the only regarding cardiac perfusion per se, there has been evidence of dysfunction in the heart wall motion as well,22-24 specially Takotsubo cardiomyopathy (TCM).25-27 Van der Bilt et al conducted a prospective, multicenter, cohort study involving 277 patients with aneurysmal SAH; 58 of which (21%) developed wall motion abnormalities, and also reported that 25 of the 57 abnormalities (9%) consisted of hypercontractility of apical segments, compatible with TCM.25

TCM was first described in 1991 by Sato et al, as a clinical entity caused by a high level of psychosomatic stress.28 This syndrome consists of a global dysfunction of the left ventricle which in turn causes transient hypokinesis, akinesis or dyskinesis of the apex and midventricle with hyperkinesis of the basal left ventricle segments.29,30 The electrocardiographic presentation of TCM resembles an acute myocardial infarction, portraying elevation of the ST-segment, T-wave inversion and prolonged QTc interval.27,28 Multiple studies have shown the association between SAH and TCM, showing predominance female phenotype (76%), especially postmenopausal women, and the mean age upon presentation was 60 ± 8 years,30-32 with a prevalence of 4-15%,31,33-35 a mortality rate of < 2% and a recurrence rate between 5 and 11% in this population.32,36,37 Kadooka and collaborators presented a study with 450 patients with diagnosis of aneurysmal SAH. Ten of these patients developed TCM along with inverted of flattened T waves (100%), QTc prolongation (< 0.45 msg; 90%), ST-segment elevation (60%) and ST-segment depression (20%). In addition, the study found that the recovery of the wall motion varied between 1 to 2 weeks, as opposed to the improvement of abnormalities on ECG that had an average of 3-4 weeks in most of the patients.38 The importance of the period between the normalization of wall motion and the abnormalities in ECG lies on the risk of developing arrhythmias like non-sustained ventricular tachycardia, paroxysmal atrial fibrillation and ventricular fibrillation.1,38-40

In Table 1, all findings described by the authors mentioned in this review are included to give a better comprehensive view of all cardiac ECG and ventricular function alterations reported in patients with SAH.

Table 1: Most common wave electrocardiographical and ventricular function abnormalities found by each author. 

Summary of findings
Morphological wave changes
Brouwers et al(4) PR interval Short
Cropp and Manning et al(15) Q wave > 1 mm
Melin and Fogelholm et al(16) T wave Inverted
Brouwers et al(4) Broad base
Rudehill et al(14) Notched
Di Pasquale et al(5) Flat
Rudehill et al(14) R wave High amplitude
Brouwers et al(4) U wave Prominent (> 0.1 mv)
Rudehill et al(14)
Di Pasquale et al(5)
Melin and Fogelholm et al(16) ST segment Elevation
Brouwers et al(4) Depression (more common)
Rudehill et al(14)
Di Pasquale et al(5)
Melin and Fogelholm et al(16) QTc interval Prolonged
Rudehill et al(14)
Di Pasquale et al(5)
Arrythmias
Di Pasquale et al(5) Supra-ventricular Sinus bradycardia
Sinus tachycardia
Wandering atrial pacemaker
Atrial fibrillation
Ventricular Ventricular tachycardia
Torsade de pointes
Premature complexes Atrial
Junctional
Ventricular
Blocks Sinoatrial
Atrioventricular
Ventricular function abnormalities
Van der Bilt et al(25) Takotsubo cardiomyopathy ST elevation / depression
Kadooka et al(38) T wave inversion
QTc interval prolongation

Conclusions

ECG abnormalities associated with aneurysmal SAH have been proved to affect discharge disposition and prolonged hospital stay,41 and because few studies have effectively involved Holter monitoring in these patients, this constitutes a matter of investigations with aims to standardize this extremely wide range of electrical cardiac complications in this central nervous system pathology.

References

1. Sommargren CE. Electrocardiographic abnormalities in patients with subarachnoid hemorrhage. Am J Crit Care. 2002; 11 (1): 48-56. [ Links ]

2. Rinkel GJ, Wijdicks EF, Hasan D et al. Outcome in patients with subarachnoid hemorrhage and negative angiography according to pattern of hemorrhage on computed tomography. Lancet. 1991; 338 (8773): 964-968. [ Links ]

3. Long B, Koyfman A, Runyon MS. Subarachnoid hemorrhage: updates in diagnosis and management. Emerg Med Clin North Am. 2017; 35 (4): 803-824. [ Links ]

4. Brouwers P, Wijdicks E, Hasan D et al. Serial electrocardiographic recording in aneurysmal subarachnoid hemorrhage. Stroke. 1989; 20 (9): 1162-1167. [ Links ]

5. Di Pasquale G, Pinelli G, Andreoli A et al. Holter detection of cardiac arrhythmias in intracranial subarachnoid hemorrhage. Am J Cardiol. 1987; 59 (6): 596-600. [ Links ]

6. Crompton MR. Hypothalamic lesions following the rupture of cerebral berry aneurysms. Brain. 1963; 86: 301-314. [ Links ]

7. Smith B. Cerebral pathology in subarachnoid hemorrhage. J Neurol Neurosurg Psychiatry. 1963; 26: 535-539. [ Links ]

8. Greenhoot JH, Reichenbach DD. Cardiac injury and subarachnoid hemorrhage. A clinical, pathological, and physiological correlation. J Neurosurg. 1969; 30 (5): 521-531. [ Links ]

9. Melville KI, Blum B, Shister HE et al. Cardiac ischemic changes and arrhythmias induced by hypothalamic stimulation. Am J Cardiol. 1963; 12: 781-791. [ Links ]

10. Rogers MC, Abildskov JA, Preston JB. Neurogenic ECG changes in critically ill patients: an experimental model. Crit Care Med. 1973; 1 (4): 192-196. [ Links ]

11. Cruickshank JM, Neil-Dwyer G, Stott AW. Possible role of catecholamines, corticosteroids, and potassium in production of electrocardiographic abnormalities associated with subarachnoid haemorrhage. Br Heart J. 1974; 36 (7): 697-706. [ Links ]

12. Parekh N, Venkatesh B, Cross D et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol. 2000; 36 (4): 1328-1335. [ Links ]

13. Gascón P, Ley TJ, Toltzis RJ et al. Spontaneous subarachnoid hemorrhage simulating acute transmural myocardial infarction. Am Heart J. 1983; 105 (3): 511-513. [ Links ]

14. Rudehill A, Olsson GL, Sundqvist K et al. ECG abnormalities in patients with subarachnoid hemorrhage and intracranial tumours. J Neurol Neurosurg Psychiatry. 1987; 50 (10): 1375-1381. [ Links ]

15. Cropp GJ, Manning GW. Electrocardiographic changes simulating myocardial ischemia and infarction associated with spontaneous intracranial hemorrhage. Circulation. 1960; 22 (1): 25-38. [ Links ]

16. Melin J, Fogelholm R. Electrocardiographic findings in subarachnoid hemorrhage. Acta Med Scand. 1983; 213 (1): 5-8. [ Links ]

17. Benninger F, Raphaeli G, Steiner I. Subarachnoid hemorrhage mimicking myocardial infarction. J Clin Neurosci. 2015; 22 (12): 1981-1982. [ Links ]

18. Murthy SB, Shah S, Venkatasubba-Rao CP et al. Clinical characteristics of myocardial stunning in acute stroke. J Clin Neurosci. 2014; 21 (8): 1279-1282. [ Links ]

19. Murthy SB, Shah S, Rao CPV et al. Neurogenic stunned myocardium following acute subarachnoid hemorrhage: pathophysiology and practical considerations. J Intensive Care Med. 2015; 30 (6): 318-325. [ Links ]

20. Donaldson JW, Pritz MB. Myocardial stunning secondary to aneurysmal subarachnoid hemorrhage. Surg Neurol. 2001; 55 (1): 12-16; discussion 16. [ Links ]

21. Köklü E, Yüksel İÖ, Bayar N et al. Subarachnoid hemorrhage that electrocardiographically mimics acute coronary syndrome: a case report. Turk Kardiyol Dern Ars. 2015; 43 (8): 730-733. [ Links ]

22. Kothavale A, Banki NM, Kopelnik A et al. Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage. Neurocrit Care. 2006; 4 (3): 199-205. [ Links ]

23. Banki NM, Kopelnik A, Dae MW et al. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation. 2005; 112 (21): 3314-3319. [ Links ]

24. Crago EA, Kerr ME, Kong Y, Baldisseri M et al. The impact of cardiac complications on outcome in the SAH population. Acta Neurol Scand. 2004; 110 (4): 248-253. [ Links ]

25. van der Bilt IA, Hasan D, van den Brink RB et al. Time course and risk factors for myocardial dysfunction after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2015; 76 (6): 700-705; discussion 705-706. [ Links ]

26. Abd TT, Hayek S, Cheng J et al. Incidence and clinical characteristics of takotsubo cardiomyopathy post-aneurysmal subarachnoid hemorrhage. Int J Cardiol. 2014; 176 (3): 1362-1364. [ Links ]

27. Spina R, Baron D, Wong S et al. Severe stress (takotsubo) cardiomyopathy following subarachnoid haemorrhage. Int J Cardiol. 2016; 210: 119-121. [ Links ]

28. Satoh H, Tateishi H, Uchida T. Takotsubo-type cardiomyopathy due to multivessel spasm. In: Kodama K, Haze K, Hon M. (eds). Clinical aspects of myocardial injury: from ischemia to heart failure. Tokyo: Kagakuhyouronsya Co.; 1990. pp. 56-64. [ Links ]

29. Dawson DK. Acute stress-induced (takotsubo) cardiomyopathy. Heart. 2018; 104 (2): 96-102. [ Links ]

30. Sharkey SW, Windenburg DC, Lesser JR et al. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol. 2010; 55 (4): 333-341. [ Links ]

31. Elgendy AY, Elgendy IY, Mansoor H et al. Clinical presentations and outcomes of Takotsubo syndrome in the setting of subarachnoid hemorrhage: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care. 2018; 7 (3): 236-245. [ Links ]

32. Templin C, Ghadri JR, Diekmann J et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. 2015; 373 (10): 929-938. [ Links ]

33. Zaroff JG, Rordorf GA, Ogilvy CS et al. Regional patterns of left ventricular systolic dysfunction after subarachnoid hemorrhage: evidence for neurally mediated cardiac injury. J Am Soc Echocardiogr. 2000; 13 (8): 774-779. [ Links ]

34. Sakr YL, Ghosn I, Vincent JL. Cardiac manifestations after subarachnoid hemorrhage: a systematic review of the literature. Prog Cardiovasc Dis. 2002; 45 (1): 67-80. [ Links ]

35. Mutoh T, Kazumata K, Terasaka S et al. Impact of transpulmonary thermodilution-based cardiac contractility and extravascular lung water measurements on clinical outcome of patients with Takotsubo cardiomyopathy after subarachnoid hemorrhage: a retrospective observational study. Crit Care [Internet]. 2014; 18 (4). Available from: https: //www.ncbi.nlm.nih.gov/pmc/articles/PMC4243958/ [ Links ]

36. Lee VH, Connolly HM, Fulgham JR et al. Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J Neurosurg. 2006; 105 (2): 264-270. [ Links ]

37. Mahmoud AN, Al-Ani M, Saad M et al. Development and validation of a simple integer risk score for prediction of in-hospital mortality following Takotsubo syndrome. Heart Lung. 2016; 45 (6): 510-514. [ Links ]

38. Kadooka K, Hadeishi H, Kadooka K. Delayed normalization of electrocardiograms in patients with takotsubo cardiomyopathy due to aneurysmal subarachnoid hemorrhage. World Neurosurg. 2017; 100: 467-473. [ Links ]

39. Akashi YJ, Nakazawa K, Sakakibara M et al. The clinical features of takotsubo cardiomyopathy. QJM. 2003; 96 (8): 563-573. [ Links ]

40. Kawai S, Suzuki H, Yamaguchi H et al. Ampulla cardiomyopathy (“Takotusbo” cardiomyopathy)--reversible left ventricular dysfunction: with ST segment elevation. Jpn Circ J. 2000; 64 (2): 156-159. [ Links ]

41. Urbaniak K, Merchant AI, Amin-Hanjani S et al. Cardiac complications after aneurysmal subarachnoid hemorrhage. Surg Neurol. 2007; 67 (1): 21-28; discussion 28-29. [ Links ]

Received: July 27, 2019; Accepted: December 03, 2019

*Corresponding author: José Miguel Gloria Escobar. Tel: (+57) 31 8844 3823. E-mail: josemiguelgloria@gmail.com

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License